Monalizumab and MEDI5752 in Patients With MSI and/or dMMR Metastatic Cancer
Clinical trial NCT06152523 · WITHDRAWN
Trial details
- NCT number
- NCT06152523
- Sponsor
- Assistance Publique - Hôpitaux de Paris
- Status
- WITHDRAWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-12-01
- Primary completion
- 2028-12-01
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.